Efficacy and Safety of Eszopiclone Across 6-Weeks of Treatment for Primary Insomnia

Patients treated with nightly eszopiclone 3 mg had better polysomnographic (through Night 29) and patient-reported measures (through Night 44) of sleep over the 6-week randomized, double-blind trial.

Continue to Efficacy and Safety of Eszopiclone Across 6-Weeks of Treatment for Primary Insomnia on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz